Sara Picó
InvestorGeneral Partner at Deep Future · Investor at Debiopharm Innovation Fund
Switzerland
Writes $200K – $5M checks · typically $1M
Find your path to Sara
196 people in our graph share verified history with Sara — schools, employers, funds. One of them is your warm intro.
Rachel PhilbinunlockedSara: together at Universidad de Sevilla (2014)
×4Sara: together at Universidad de Sevilla
×6Sara: together at Universidad Autónoma de Madrid
Sara: together at University of Lausanne - UNIL
Experience
- DebiopharmScientific Fellow Strategic Partneringcurrent2025 — presentLausanne, Vaud, Switzerland
- Barcelona ActivaStartup Mentor2025
- PIPRABusiness Development2025Zurich, Switzerland
- DebiopharmVenture Capital Analyst Intern2024 — 2025Lausanne, Vaud, Switzerland
- University of Lausanne - UNILAging Postdoctoral researcher2022 — 2024Lausanne, Vaud, Switzerland
- Centro de Biología Molecular Severo Ochoa, CBMSONeuroscience researcher (PhD)2017 — 2022Madrid, Community of Madrid, Spain
- Centro de Biología Molecular Severo Ochoa, CBMSOResearch Associate2015 — 2017Madrid, Community of Madrid, Spain
- cicCartujaResearch Associate2013 — 2015Seville, Andalusia, Spain
Skills & more
RoedoresStart-up VenturesProject ManagementBusiness StrategyMarket Research1Business Development1Start-up Support1Scientific BackgroundMentoringProject TeamsStudy ReportsProject Plans
+12 more
Project LeadershipExternal RelationshipsLiteratureCompetitive IntelligenceInversionesLaboratory SkillsSocial Media CommunicationsPandas (Software)Data AnalysisInglésEspañolLiterature ReviewsLanguages English · French · Italian · Spanish
- Introduction to Drug Hunting — Novartis
- Foundations of Project Management — Google
- Private Equity and Venture Capital — Università Bocconi
- MLOps — Canvas Credentials (Badgr)
- TensorFlow & Keras — Canvas Credentials (Badgr)
- SQL — Canvas Credentials (Badgr)
- Maths for Data Science — Canvas Credentials (Badgr)
- Deep Learning — Canvas Credentials (Badgr)
- Machine Learning Engineer — Canvas Credentials (Badgr)
- Data Wrangling — Canvas Credentials (Badgr)
From Sara's professional profile.
Colleagues at Deep Future
Network1
Investors connected to Sara in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Sara Picó?
- Investor at Debiopharm Innovation Fund
- Where does Sara Picó work?
- Sara Picó is General Partner at Deep Future.
- What check size does Sara Picó write?
- Sara Picó typically writes checks of $200K – $5M.
- Where did Sara Picó go to school?
- Sara Picó studied at The Bridge | Digital Talent Accelerator (Bootcamp in Data Science | Artificial intelligence | Machine Learning); Universidad Autónoma de Madrid (PhD in Molecular Biosciences (Neuroscience), Research); Universidad Autónoma de Madrid (Master in Molecular Biomedicine).
Same school
Also attended The Bridge | Digital Talent Accelerator1
Also attended Universidad Autónoma de Madrid100
Borja FernándezGeneral Partner at Inveready Technology Investment GroupAna MartínezGeneral Partner at Inveready Technology Investment GroupMiguel Garcia DiazVice President for Research, Scholarship and Innovation at University of Delaware at The Innovation SpaceCristina Garcia-MargalloInvestor at KfundRyan GembalaFounder & Managing Partner at Pathbreaker VenturesJulia SalaverríaManaging Partner at Ysios Capital
+ 94 more
Also attended Universidad de Sevilla68
Andrew BrochuController at Castle Island VenturesLauren DenshamPartner, Head of Portfolio Services & Impact at Energize VenturesBorja BreñaPartner at Nauta CapitalRachel PhilbinVice President at Long Ridge Equity PartnersCourtney SawatzkeEarly-stage Investor at Active PartnersCristina GarmendiaGeneral Partner at Ysios Capital
+ 62 more
Also attended Colegio Internacional de Sevilla San Francisco de Paula1
Shared employers
Also worked at Barcelona Activa4
Also worked at PIPRA4
Also worked at Debiopharm9
Marc CikesManaging Director at Debiopharm Innovation FundTom GibbsSenior Investment Director at Debiopharm Innovation FundVincent LepreuxInvestment Principal at Debiopharm Innovation FundTanja DoweManaging Director at Angelini VenturesBertrand DucreyChief Executive Officer, Debiopharm International & Senior Vice-Chairman, Debiopharm at Debiopharm Innovation FundAngela ZubelChief Development Officer, Research & Development at Debiopharm Innovation Fund
+ 3 more
Also worked at University of Lausanne - UNIL18
Yannick RitschelInvestor at Backbone VenturesGregor HirtCIO Multi Asset at Allianz Global InvestorsMaria TahriPrincipal at AlvenLuca MianInnovation Specialist at META GroupDavid ShinInvestor at Dash FundPavel ErmolineHead of Venture Capital and Direct Investing at Moonfare
+ 12 more



































